Search hospitals > California > San Diego

Kaiser Permanente-San Diego Mission

Claim this profile
San Diego, California 92108
Global Leader in Parotid Gland Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Cancer
Conducts research for Non-Small Cell Lung Cancer
178 reported clinical trials
11 medical researchers
Photo of Kaiser Permanente-San Diego Mission in San DiegoPhoto of Kaiser Permanente-San Diego Mission in San Diego

Summary

Kaiser Permanente-San Diego Mission is a medical facility located in San Diego, California. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Lung Cancer, Cancer, Non-Small Cell Lung Cancer and other specialties. Kaiser Permanente-San Diego Mission is involved with conducting 178 clinical trials across 378 conditions. There are 11 research doctors associated with this hospital, such as Robert M. Cooper, Gary L. Buchschacher, Helen H. Moon, and Ashraf R. Aziz.

Area of expertise

1Parotid Gland Cancer
Global Leader
Kaiser Permanente-San Diego Mission has run 46 trials for Parotid Gland Cancer. Some of their research focus areas include:
Stage IV
Stage I
Stage II
2Breast Cancer
Global Leader
Kaiser Permanente-San Diego Mission has run 28 trials for Breast Cancer. Some of their research focus areas include:
HER2 negative
Stage IV
ER positive

Top PIs

Clinical Trials running at Kaiser Permanente-San Diego Mission

Lung Cancer
Breast Cancer
Testicular cancer
Non-Small Cell Lung Cancer
Testicular Carcinoma
Ovarian Carcinoma
Ovarian Tumors
Ovarian Choriocarcinoma
Acute Lymphoblastic Leukemia
Parotid Gland Cancer
Image of trial facility.

Crizotinib

for Non-Small Cell Lung Cancer

This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Image of trial facility.

Multiple Therapies

for Stage III Non-Small Cell Lung Cancer

This trial is testing different treatments to see how well they work and how safe they are. It focuses on patients with advanced lung cancer that cannot be removed by surgery and have specific biological markers. The goal is to find out if these treatments can stop the cancer from growing or spreading and improve patients' health.
Recruiting2 awards Phase 317 criteria
Image of trial facility.

Targeted Therapy Screening

for Lung Cancer

This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will determine to which sub-study, within this protocol, a participant will be assigned to compare new targeted cancer therapy, designed to block the growth and spread of cancer, or combinations to standard of care therapy with the ultimate goal of being able to approve new targeted therapies in this setting. In addition, the protocol includes non-match sub-studies which will include all screened patients not eligible for any of the biomarker-driven sub-studies.
Recruiting1 award Phase 2 & 313 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Kaiser Permanente-San Diego Mission?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security